Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

J&J Adds New Dimension To Drug Discovery Efforts With 3DP Acquisition

Executive Summary

Johnson & Johnson's purchase of 3-Dimensional Pharmaceuticals has more of a research focus than its other recent drug acquisitions

You may also be interested in...



Pharma/Biotech Deals: Are Today’s Collaborations Tomorrow’s Acquisitions?

Big pharma and biotech companies are increasingly looking at collaborations as a pathway to acquisition, Kirkpatrick & Lockhart attorney Eileen Smith Ewing said at the Biotechnology Industry Organization annual meeting in Washington, D.C. June 23

Pharma/Biotech Deals: Are Today’s Collaborations Tomorrow’s Acquisitions?

Big pharma and biotech companies are increasingly looking at collaborations as a pathway to acquisition, Kirkpatrick & Lockhart attorney Eileen Smith Ewing said at the Biotechnology Industry Organization annual meeting in Washington, D.C. June 23

J&J Increases Alza Ante By $5 Bil. Over Abbott: Concerta Has J&J Upbeat

Johnson & Johnson is offering about 67% ($5 bil.) more than Abbott did in 1999 to bring Alza's $700 mil. annual sales product line and its extended-release product development skills into the J&J family.

Related Content

UsernamePublicRestriction

Register

OM017301

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel